Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 232 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ACYCLOVIR | 200MG | TABLET | Resolved | 2022-04-08 | 2022-04-13 | 158339 |
APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2022-04-08 | 2022-04-13 | 158342 |
APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-12-24 | 2022-04-14 | 151886 |
APO-PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2022-02-04 | 2022-04-15 | 154187 |
APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2022-03-18 | 2022-04-18 | 156993 |
APO-SIMVASTATIN | 80MG | TABLET | Resolved | 2022-01-14 | 2022-04-18 | 152776 |
APO-TADALAFIL PAH | 20MG | TABLET | Resolved | 2022-02-18 | 2022-04-18 | 155321 |
APO-MIDODRINE | 2.5MG | TABLET | Resolved | 2022-01-07 | 2022-04-22 | 152313 |
APO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2022-04-08 | 2022-04-22 | 158370 |
APO-MIDODRINE | 5MG | TABLET | Resolved | 2022-01-21 | 2022-04-29 | 153278 |
APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2022-04-01 | 2022-04-29 | 157701 |
APO-SIMVASTATIN | 20MG | TABLET | Resolved | 2022-04-01 | 2022-04-29 | 157704 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2022-03-25 | 2022-04-29 | 157332 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2022-03-11 | 2022-05-05 | 156540 |
APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Actual shortage | 2022-01-07 | 2022-05-06 | 152332 |
APO-TRAZODONE D TABLETS 150MG | 150MG | TABLET | Resolved | 2022-02-04 | 2022-05-06 | 154205 |
APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-02-18 | 2022-05-06 | 155317 |
APO-QUINAPRIL/HCTZ | 12.5MG 20MG | TABLET | Actual shortage | 2022-03-04 | 2022-05-09 | 156039 |
APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Actual shortage | 2021-11-05 | 2022-05-09 | 148876 |
APO-QUINAPRIL/HCTZ | 12.5MG 10MG | TABLET | Actual shortage | 2022-03-25 | 2022-05-09 | 157326 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CIPROFLOX | 250MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60379 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60382 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60385 |
APO-CLONAZEPAM | .5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60402 |
APO-CYCLOBENZAPRINE | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60405 |
APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2018-09-15 | 60438 |
APO-DONEPEZIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60443 |
APO-DONEPEZIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60447 |
APO-ESCITALOPRAM | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60471 |
APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |